00455.HK
Tianda Pharmaceuticals Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.09
+0.00%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -16.1%
- EBITDA
- +3.0%
- EBIT
- +0.1%
- Net income
- -14.1%
- EPS
- -14.4%
- Free cash flow
- -62.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025